Safety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malaria

BACKGROUND: Despite the widespread use and availability of rapidly acting anti-malarials, the fatality rate of severe malaria in sub-Saharan Africa remains high. Adjunctive therapies that target the host response to malaria infection may further decrease mortality over that of anti-malarial agents a...

Descripción completa

Detalles Bibliográficos
Autores principales: Varo, Rosauro, Crowley, Valerie M., Sitoe, Antonio, Madrid, Lola, Serghides, Lena, Bila, Rubao, Mucavele, Helio, Mayor, Alfredo, Bassat, Quique, Kain, Kevin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442675/
https://www.ncbi.nlm.nih.gov/pubmed/28535809
http://dx.doi.org/10.1186/s12936-017-1858-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442675/
https://www.ncbi.nlm.nih.gov/pubmed/28535809
http://dx.doi.org/10.1186/s12936-017-1858-0

Ejemplares similares